Lymphoblastoid Cell lines: a Continuous in Vitro Source of Cells to Study Carcinogen Sensitivity and DNA Repair

Obtaining a continuous source of normal cells or DNA from a single individual has always been a rate limiting step in biomedical research. Availability of Lymphoblastoid cell lines (LCLs) as a surrogate for isolated or cryopreserved peripheral blood lymphocytes has substantially accelerated the process of biological investigations. LCLs can be established by in vitro infection of resting B cells from peripheral blood with Epstein Barr Virus (EBV) resulting in a continuous source, bearing negligible genetic and phenotypic alterations. Being a spontaneous replicating source, LCLs fulfil the requirement of constant supply of starting material for variety of assays, sparing the need of re-sampling. There is a reason to believe that LCLs are in close resemblance with the parent lymphocytes based on the ample supporting observations from a variety of studies showing significant level of correlation at molecular and functional level. LCLs, which carry the complete set of germ line genetic material, have been instrumental in general as a source of biomolecules and a system to carry out various immunological and epidemiological studies. Furthermore, in recent times their utility for analysing the whole human genome has extensively been documented. This proves the usefulness of LCLs in various genetic and functional studies. There are a few contradictory reports that have questioned the employment of LCLs as parent surrogate. Regardless of some inherent limitations LCLs are increasingly being considered as an important resource for genetic and functional research.

[1]  R. Santella,et al.  Removal of benzo(a)pyrene diol epoxide (BPDE)‐DNA adducts as a measure of DNA repair capacity in lymphoblastoid cell lines from sisters discordant for breast cancer , 2002, Environmental and molecular mutagenesis.

[2]  G. Speit,et al.  Mutagen Sensitivity of Human Lymphoblastoid Cells with a BRCA1 Mutation , 2003, Breast Cancer Research and Treatment.

[3]  E. Sturgis,et al.  DNA repair in lymphoblastoid cell lines from patients with head and neck cancer. , 1999, Archives of otolaryngology--head & neck surgery.

[4]  H. Christiansen,et al.  A putatively functional haplotype in the gene encoding transforming growth factor beta-1 as a potential biomarker for radiosensitivity. , 2011, International journal of radiation oncology, biology, physics.

[5]  G. Peters,et al.  EBNA‐2 and EBNA‐LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein‐Barr virus. , 1994, The EMBO journal.

[6]  K. Ory,et al.  DNA damage-related gene expression as biomarkers to assess cellular response after gamma irradiation of a human lymphoblastoid cell line , 2000, Oncogene.

[7]  I. Demuth,et al.  Extreme variation in apoptosis capacity amongst lymphoid cells of Nijmegen breakage syndrome patients. , 2008, European journal of cell biology.

[8]  L. Samson,et al.  Genomic predictors of interindividual differences in response to DNA damaging agents. , 2008, Genes & development.

[9]  S. Bernacki,et al.  Characterization of publicly available lymphoblastoid cell lines for disease-associated mutations in 11 genes. , 2005, Clinical chemistry.

[10]  E. Kieff,et al.  Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity , 1988, Journal of virology.

[11]  M. Mullendore,et al.  Mitochondrial DNA Mutations in Pancreatic Cancer , 2006, International journal of gastrointestinal cancer.

[12]  L. Hutt-Fletcher,et al.  Alternate replication in B cells and epithelial cells switches tropism of Epstein–Barr virus , 2002, Nature Medicine.

[13]  W. Hammerschmidt,et al.  Genetic analysis of immortalizing functions of Epstein–Barr virus in human B lymphocytes , 1989, Nature.

[14]  G. Nemerow,et al.  Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d , 1987, Journal of virology.

[15]  I. M. Jones,et al.  Prospective analysis of DNA damage and repair markers of lung cancer risk from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. , 2010, Carcinogenesis.

[16]  T. Ide,et al.  Steps Involved in Immortalization and Tumorigenesis in Human B-Lymphoblastoid Cell Lines Transformed by Epstein-Barr Virus , 2004, Cancer Research.

[17]  T. Carey,et al.  Identification of new minimally lost regions on 18q in head and neck squamous cell carcinoma. , 2000, Cancer research.

[18]  G. Speit,et al.  Radiosensitivity of lymphoblastoid cell lines with a heterozygous BRCA1 mutation is not detected by the comet assay and pulsed field gel electrophoresis. , 2005, Mutagenesis.

[19]  H. Thierens,et al.  The use of EBV-transformed cell lines of breast cancer patients to measure chromosomal radiosensitivity. , 2004, Mutagenesis.

[20]  F. Galibert,et al.  Cloning and expression of a cDNA for human thioredoxin. , 1988, The Journal of biological chemistry.

[21]  D. Kennedy,et al.  DNA repair capacity of lymphoblastoid cell lines from sisters discordant for breast cancer. , 2005, Journal of the National Cancer Institute.

[22]  Richard M Walmsley,et al.  Assessment of the genotoxicity of S9-generated metabolites using the GreenScreen HC GADD45a-GFP assay. , 2008, Mutagenesis.

[23]  M. Pawlita,et al.  Epstein–Barr Virus Nuclear Antigen 2–Estrogen Receptor Fusion Proteins Transactivate Viral and Cellular Genes and Interact with RBP-Jκ in a Conditional Fashion , 1995 .

[24]  Z. Talebizadeh,et al.  Feasibility and relevance of examining lymphoblastoid cell lines to study role of microRNAs in autism , 2008, Autism research : official journal of the International Society for Autism Research.

[25]  B. Kempkes,et al.  The Proto-Oncogene c-myc Is a Direct Target Gene of Epstein-Barr Virus Nuclear Antigen 2 , 1999, Journal of Virology.

[26]  Joshua T. Herbeck,et al.  Fidelity of SNP Array Genotyping Using Epstein Barr Virus-Transformed B-Lymphocyte Cell Lines: Implications for Genome-Wide Association Studies , 2009, PloS one.

[27]  L. Young,et al.  Epstein–Barr virus: 40 years on , 2004, Nature Reviews Cancer.

[28]  M. Filipič,et al.  Different sensitivities of human colon adenocarcinoma (CaCo-2), astrocytoma (IPDDC-A2) and lymphoblastoid (NCNC) cell lines to microcystin-LR induced reactive oxygen species and DNA damage. , 2008, Toxicon : official journal of the International Society on Toxinology.

[29]  Aldi Kraja,et al.  Genome-wide discovery of loci influencing chemotherapy cytotoxicity. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[30]  P. A. Biro,et al.  Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[31]  U. Vogel,et al.  8-Oxoguanine DNA-glycosylase repair activity and expression: a comparison between cryopreserved isolated lymphocytes and EBV-derived lymphoblastoid cell lines. , 2011, Mutation research.

[32]  A. Heck,et al.  Human lymphoblastoid proteome analysis reveals a role for the inhibitor of acetyltransferases complex in DNA double-strand break response. , 2006, Cancer research.

[33]  D. Watson,et al.  Comparison of gene expression changes induced in mouse and human cells treated with direct‐acting mutagens , 2004, Environmental and molecular mutagenesis.

[34]  F. Poirier,et al.  Proteomic map and database of lymphoblastoid proteins. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[35]  P. Farrell Epstein-Barr virus immortalizing genes. , 1995, Trends in microbiology.

[36]  D. Thorley-Lawson,et al.  B cell activation and the establishment of Epstein-Barr virus latency , 1988, The Journal of experimental medicine.

[37]  D. Kennedy,et al.  Double-strand breaks repair in lymphoblastoid cell lines from sisters discordant for breast cancer from the New York site of the BCFR. , 2008, Carcinogenesis.

[38]  C. R. Leemans,et al.  Microarray Analysis of Bleomycin-Exposed Lymphoblastoid Cells for Identifying Cancer Susceptibility Genes , 2006, Molecular Cancer Research.

[39]  T. Toda,et al.  Proteome analysis of Epstein-Barr virus-transformed B-lymphoblasts and the proteome database. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[40]  M. Pawlita,et al.  Epstein-Barr virus nuclear antigen 2-estrogen receptor fusion proteins transactivate viral and cellular genes and interact with RBP-J kappa in a conditional fashion. , 1995, Virology.

[41]  E. Kieff,et al.  Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[42]  W. Hammerschmidt,et al.  Epstein–Barr virus‐mediated B‐cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor , 1998, The EMBO journal.

[43]  T. Dörk,et al.  Characterization of ATM gene mutations in 66 ataxia telangiectasia families. , 1999, Human molecular genetics.

[44]  Zhifu Sun,et al.  Genetic Variation Predicting Cisplatin Cytotoxicity Associated with Overall Survival in Lung Cancer Patients Receiving Platinum-Based Chemotherapy , 2011, Clinical Cancer Research.

[45]  L Sie,et al.  Utility of lymphoblastoid cell lines , 2009, Journal of neuroscience research.

[46]  C. Tyler-Smith,et al.  Genetic instability in EBV-transformed lymphoblastoid cell lines. , 2004, Biochimica et biophysica acta.

[47]  M. Spitz,et al.  DNA repair capacity correlates with mutagen sensitivity in lymphoblastoid cell lines. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[48]  P. Fortina,et al.  Whole-exome sequencing of DNA from peripheral blood mononuclear cells (PBMC) and EBV-transformed lymphocytes from the same donor , 2011, BMC Genomics.

[49]  G. Mosialos,et al.  Epstein-Barr virus transformation: involvement of latent membrane protein 1-mediated activation of NF-κB , 1999, Oncogene.

[50]  G. Matullo,et al.  Unsuitability of lymphoblastoid cell lines as surrogate of cryopreserved isolated lymphocytes for the analysis of DNA double-strand break repair activity. , 2010, Mutation research.

[51]  G. Mosialos,et al.  Epstein-barr virus transformation: involvement of latent membrane protein 1-mediated activation of NF-kappaB. , 1999, Oncogene.

[52]  Heidemarie Neitzel,et al.  A routine method for the establishment of permanent growing lymphoblastoid cell lines , 1986, Human Genetics.

[53]  A. Iolascon,et al.  Elevated expression and polymorphisms of SOCS3 influence patient response to antiviral therapy in chronic hepatitis C , 2007, Gut.

[54]  M. Desai,et al.  Polymorphisms in Nucleotide Excision Repair Genes and DNA Repair Capacity Phenotype in Sisters Discordant for Breast Cancer , 2006, Cancer Epidemiology Biomarkers & Prevention.